Cargando…

Development and validation of a risk prediction model for lost to follow-up among adults on active antiretroviral therapy in Ethiopia: a retrospective follow-up study

BACKGROUND: Over 420,000 people have initiated life-saving antiretroviral therapy (ART) in Ethiopia; however, lost-to-follow-up (LTFU) rates continues to be high. A clinical decision tool is needed to identify patients at higher risk for LTFU to provide individualized risk prediction to intervention...

Descripción completa

Detalles Bibliográficos
Autores principales: Fentie, Dawit Tefera, Kassa, Getahun Molla, Tiruneh, Sofonyas Abebaw, Muche, Achenef Asmamaw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449961/
https://www.ncbi.nlm.nih.gov/pubmed/36071386
http://dx.doi.org/10.1186/s12879-022-07691-x
_version_ 1784784418205859840
author Fentie, Dawit Tefera
Kassa, Getahun Molla
Tiruneh, Sofonyas Abebaw
Muche, Achenef Asmamaw
author_facet Fentie, Dawit Tefera
Kassa, Getahun Molla
Tiruneh, Sofonyas Abebaw
Muche, Achenef Asmamaw
author_sort Fentie, Dawit Tefera
collection PubMed
description BACKGROUND: Over 420,000 people have initiated life-saving antiretroviral therapy (ART) in Ethiopia; however, lost-to-follow-up (LTFU) rates continues to be high. A clinical decision tool is needed to identify patients at higher risk for LTFU to provide individualized risk prediction to intervention. Therefore, this study aimed to develop and validate a statistical risk prediction tool that predicts the probability of LTFU among adult clients on ART. METHODS: A retrospective follow-up study was conducted among 432 clients on ART in Gondar Town, northwest, Ethiopia. Prognostic determinates included in the analysis were determined by multivariable logistic regression. The area under the receiver operating characteristic (AUROC) and calibration plot were used to assess the model discriminative ability and predictive accuracy, respectively. Individual risk prediction for LTFU was determined using both regression formula and score chart rule. Youden index value was used to determine the cut-point for risk classification. The clinical utility of the model was evaluated using decision curve analysis (DCA). RESULTS: The incidence of LTFU was 11.19 (95% CI 8.95–13.99) per 100-persons years of observation. Potential prognostic determinants for LTFU were rural residence, not using prophylaxis (either cotrimoxazole or Isoniazid or both), patient on appointment spacing model (ASM), poor drug adherence level, normal Body mass index (BMI), and high viral load (viral copies > 1000 copies/ml). The AUROC was 85.9% (95% CI 82.0–89.6) for the prediction model and the risk score was 81.0% (95% CI 76.7–85.3) which was a good discrimination probability. The maximum sensitivity and specificity of the probability of LTFU using the prediction model were 72.07% and 83.49%, respectively. The calibration plot of the model was good (p-value = 0.350). The DCA indicated that the model provides a higher net benefit following patients based on the risk prediction tool. CONCLUSION: The incidence of LTFU among clients on ART in Gondar town was high (> 3%). The risk prediction model presents an accurate and easily applicable prognostic prediction tool for clients on ART. A prospective follow-up study and external validation of the model is warranted before using the model. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07691-x.
format Online
Article
Text
id pubmed-9449961
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94499612022-09-07 Development and validation of a risk prediction model for lost to follow-up among adults on active antiretroviral therapy in Ethiopia: a retrospective follow-up study Fentie, Dawit Tefera Kassa, Getahun Molla Tiruneh, Sofonyas Abebaw Muche, Achenef Asmamaw BMC Infect Dis Research BACKGROUND: Over 420,000 people have initiated life-saving antiretroviral therapy (ART) in Ethiopia; however, lost-to-follow-up (LTFU) rates continues to be high. A clinical decision tool is needed to identify patients at higher risk for LTFU to provide individualized risk prediction to intervention. Therefore, this study aimed to develop and validate a statistical risk prediction tool that predicts the probability of LTFU among adult clients on ART. METHODS: A retrospective follow-up study was conducted among 432 clients on ART in Gondar Town, northwest, Ethiopia. Prognostic determinates included in the analysis were determined by multivariable logistic regression. The area under the receiver operating characteristic (AUROC) and calibration plot were used to assess the model discriminative ability and predictive accuracy, respectively. Individual risk prediction for LTFU was determined using both regression formula and score chart rule. Youden index value was used to determine the cut-point for risk classification. The clinical utility of the model was evaluated using decision curve analysis (DCA). RESULTS: The incidence of LTFU was 11.19 (95% CI 8.95–13.99) per 100-persons years of observation. Potential prognostic determinants for LTFU were rural residence, not using prophylaxis (either cotrimoxazole or Isoniazid or both), patient on appointment spacing model (ASM), poor drug adherence level, normal Body mass index (BMI), and high viral load (viral copies > 1000 copies/ml). The AUROC was 85.9% (95% CI 82.0–89.6) for the prediction model and the risk score was 81.0% (95% CI 76.7–85.3) which was a good discrimination probability. The maximum sensitivity and specificity of the probability of LTFU using the prediction model were 72.07% and 83.49%, respectively. The calibration plot of the model was good (p-value = 0.350). The DCA indicated that the model provides a higher net benefit following patients based on the risk prediction tool. CONCLUSION: The incidence of LTFU among clients on ART in Gondar town was high (> 3%). The risk prediction model presents an accurate and easily applicable prognostic prediction tool for clients on ART. A prospective follow-up study and external validation of the model is warranted before using the model. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07691-x. BioMed Central 2022-09-07 /pmc/articles/PMC9449961/ /pubmed/36071386 http://dx.doi.org/10.1186/s12879-022-07691-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Fentie, Dawit Tefera
Kassa, Getahun Molla
Tiruneh, Sofonyas Abebaw
Muche, Achenef Asmamaw
Development and validation of a risk prediction model for lost to follow-up among adults on active antiretroviral therapy in Ethiopia: a retrospective follow-up study
title Development and validation of a risk prediction model for lost to follow-up among adults on active antiretroviral therapy in Ethiopia: a retrospective follow-up study
title_full Development and validation of a risk prediction model for lost to follow-up among adults on active antiretroviral therapy in Ethiopia: a retrospective follow-up study
title_fullStr Development and validation of a risk prediction model for lost to follow-up among adults on active antiretroviral therapy in Ethiopia: a retrospective follow-up study
title_full_unstemmed Development and validation of a risk prediction model for lost to follow-up among adults on active antiretroviral therapy in Ethiopia: a retrospective follow-up study
title_short Development and validation of a risk prediction model for lost to follow-up among adults on active antiretroviral therapy in Ethiopia: a retrospective follow-up study
title_sort development and validation of a risk prediction model for lost to follow-up among adults on active antiretroviral therapy in ethiopia: a retrospective follow-up study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449961/
https://www.ncbi.nlm.nih.gov/pubmed/36071386
http://dx.doi.org/10.1186/s12879-022-07691-x
work_keys_str_mv AT fentiedawittefera developmentandvalidationofariskpredictionmodelforlosttofollowupamongadultsonactiveantiretroviraltherapyinethiopiaaretrospectivefollowupstudy
AT kassagetahunmolla developmentandvalidationofariskpredictionmodelforlosttofollowupamongadultsonactiveantiretroviraltherapyinethiopiaaretrospectivefollowupstudy
AT tirunehsofonyasabebaw developmentandvalidationofariskpredictionmodelforlosttofollowupamongadultsonactiveantiretroviraltherapyinethiopiaaretrospectivefollowupstudy
AT mucheachenefasmamaw developmentandvalidationofariskpredictionmodelforlosttofollowupamongadultsonactiveantiretroviraltherapyinethiopiaaretrospectivefollowupstudy